A multidisciplinary team aims to build a more inclusive AI shaped by global cultures and knowledge – one of three projects that make up Cornell’s new GlobalGrand Challenge: The Future.
A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
Faculty and staff within Cornell’s Department of Public & Ecosystem Health have been funded by the U.S. Centers for Disease Control and Prevention’s (CDC) National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce to help strengthen the public health system in the United States.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
A classic psychedelic was found to activate a cell type in the brain of mice and rats that silences other neighboring neurons, providing insight into how such drugs reduce anxiety.
Rural hospitals and hospitals that treat patients regardless of their ability to pay have been hampered by federal rules limiting their access to funding for capital projects, which has led to institutionalized racism in hospitals, researchers have found.
The collection of essays by Shepley and other authors is intended for students, academics and practitioners in all design fields to inspire societal contribution and celebrate collaboration.
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.
